semaglutide patent expiration Indian pharma launches low-cost Ozempic generics as expires semaglutide patent expiration canada The

doi: 10.1136/gutjnl-2018-316723 11 CaniP

Wegovy and other semaglutide medications have experienced periods of limited availability, making it difficult for some patients to obtain their prescriptions.[5] During the height of the shortages, healthcare providers sometimes had to adjust dosing strategies to help patients maintain treatment.[6] Novo Nordisk, the manufacturer of Wegovy and Ozempic, has reported efforts to increase production and improve supply, though demand may still exceed availability in some areas.[7] Compounded semaglutide may be more readily available in some cases and may be less expensive for certain patients

Oral delivery of peptides and proteins: pharmacokinetic boundaries, negative selection, and route triage

Based on the evidence examined in this analysis: The regulatory landscape has evolved significantly